Joshua Lev Sells 5,000 Shares of electroCore (NASDAQ:ECOR) Stock

electroCore, Inc. (NASDAQ:ECORGet Free Report) CFO Joshua Lev sold 5,000 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $9.88, for a total transaction of $49,400.00. Following the completion of the transaction, the chief financial officer directly owned 84,889 shares of the company’s stock, valued at $838,703.32. This trade represents a 5.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

electroCore Stock Up 9.3%

ECOR opened at $10.35 on Thursday. electroCore, Inc. has a 12 month low of $4.41 and a 12 month high of $10.95. The company has a fifty day simple moving average of $7.79 and a 200 day simple moving average of $7.27. The stock has a market cap of $93.32 million, a P/E ratio of -6.23 and a beta of 0.92.

electroCore (NASDAQ:ECORGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.42) by $0.09. The business had revenue of $9.45 million for the quarter, compared to the consensus estimate of $9.49 million. electroCore had a negative return on equity of 1,956.38% and a negative net margin of 39.96%. On average, equities research analysts expect that electroCore, Inc. will post -1.4 earnings per share for the current fiscal year.

Institutional Investors Weigh In On electroCore

A number of hedge funds and other institutional investors have recently made changes to their positions in ECOR. Two Sigma Investments LP lifted its position in electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after acquiring an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in electroCore in the 1st quarter worth $153,000. WealthShield Partners LLC bought a new position in electroCore during the 1st quarter worth about $157,000. Jane Street Group LLC increased its holdings in electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after purchasing an additional 19,599 shares in the last quarter. Finally, DRW Securities LLC acquired a new stake in shares of electroCore in the 4th quarter valued at about $264,000. 26.74% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $18.00.

View Our Latest Analysis on ECOR

More electroCore News

Here are the key news stories impacting electroCore this week:

  • Positive Sentiment: electroCore’s Truvaga® device was named the Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards. The recognition may improve consumer awareness and support the company’s expansion into the wellness market beyond its prescription-focused nVNS products. Truvaga Named Best Luxury Biohacking & Longevity Brand
  • Neutral Sentiment: Reported short interest was zero shares as of August 25, indicating that short sellers are not a significant factor behind current trading activity. Institutional investors own approximately 26.74% of ECOR, with some funds recently adding to their positions.
  • Negative Sentiment: CFO Joshua Lev disclosed a series of stock sales totaling 20,000 shares: 12,000 shares at an average $10.22, 5,000 at $9.88 and 3,000 at $9.36. The transactions reduced his direct ownership to 84,889 shares and occurred near the stock’s recent highs, potentially weighing on investor sentiment. electroCore CFO Insider Sales
  • Negative Sentiment: electroCore remains unprofitable. In its latest quarter, the company reported a loss of $0.33 per share—better than the expected $0.42 loss—while revenue of $9.45 million was slightly below the $9.49 million consensus estimate. Analysts expect a full-year loss of approximately $1.40 per share, and the overall analyst rating remains “Hold,” alongside a separate “Sell” rating.

About electroCore

(Get Free Report)

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.

Read More

Insider Buying and Selling by Quarter for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.